Synergy between Kaposi's sarcoma-associated herpesvirus (KSHV) vIL-6 and HIV-1 Nef protein in promotion of angiogenesis and oncogenesis: role of the AKT signaling pathway

Synergy between Kaposi's sarcoma-associated herpesvirus (KSHV) vIL-6 and HIV-1 Nef protein in promotion of angiogenesis and oncogenesis: role of the AKT signaling pathway
复制标题

卡波西肉瘤相关疱疹病毒 (KSHV) vIL-6 和 HIV-1 Nef 蛋白在促进血管生成和肿瘤发生中的协同作用:AKT 信号通路的作用

DOI:
10.1038/onc.2013.136
复制
发表时间:
2014-04
期刊:
影响因子:
8
通讯作者:
Lu, C.
Lu, C.
中科院分区:
医学1区
文献类型:
--
作者:
Zhou, F.;Zhu, J.;Qin, D.;Lu, C.

文献摘要

参考文献

被引文献

相似文献

Kaposi's sarcoma-associated herpesvirus (KSHV) is the cause of Kaposi's sarcoma (KS), which is the most common AIDS-associated malignancy. KS is characterized by neovascularization and spindle cell proliferation. The interaction between HIV-1 and KSHV has a central role in promoting the aggressive manifestations of KS in AIDS patients; however, the pathogenesis underlying AIDS-related KS (AIDS–KS) remains unknown. Herein, we examined the potential of HIV-1 negative factor (Nef) to impact KSHV viral interleukin-6 (vIL-6)-induced angiogenesis and tumorigenesis. In vitro experiments showed that exogenous Nef penetrated vIL-6-expressing endothelial cells. Both internalized and ectopic expression of Nef in endothelial cells and fibroblasts synergized with vIL-6 to promote vascular tube formation and cell proliferation. Using a chicken chorioallantoic membrane (CAM) model, we demonstrated that Nef synergistically promotes vIL-6-induced angiogenesis and tumorigenesis. Animal experiments further showed that Nef facilitates vIL-6-induced angiogenesis and tumor formation in athymic nu/nu mice. Mechanistic studies indicated that Nef synergizes with vIL-6 to enhance angiogenesis and tumorigenesis by activating the AKT pathway in the CAM model, as well as nude mice. LY294002, a specific inhibitor of phosphatidylinositol-3-kinase (PI3K), significantly impaired the ability of Nef to promote vIL-6-induced tumorigenesis in an allograft model of nude mice. Our data provide first-line evidence that Nef may contribute to the pathogenesis underlying AIDS–KS in synergy with vIL-6. These novel findings also suggest that targeting the PI3K/AKT signal may be a potentially effective therapeutic approach in AIDS–KS patients.
DOI: 10.1089/aid.2009.0170
发表时间: 2011-02-01
影响因子: 1.5
作者:
Raymond, A. D.;Campbell-Sims, T. C.;Powell, M. D.
通讯作者: Powell, M. D.
DOI: 10.1097/00002030-199601001-00008
发表时间: 1996-01
期刊: AIDS
影响因子: 3.8
作者:
S. Strathdee;P. Veugelers;P. Moore
通讯作者: S. Strathdee;P. Veugelers;P. Moore
DOI: 10.1016/0092-8674(91)90097-i
发表时间: 1991-05-17
期刊: CELL
影响因子: 64.5
作者:
KESTLER, HW;RINGLER, DJ;DESROSIERS, RC
通讯作者: DESROSIERS, RC
1 型单纯疱疹病毒诱导卡波西肉瘤相关疱疹病毒的裂解周期复制:IL-10 和 IL-4 的参与
DOI: 10.1111/j.1462-5822.2007.01079.x
发表时间: 2008-03-01
影响因子: 3.4
作者:
Qin, Di;Zeng, Yi;Lu, Chun
通讯作者: Lu, Chun
DOI: 10.1038/330266a0
发表时间: 1987-11-19
期刊: NATURE
影响因子: 64.8
作者:
GUY, B;KIENY, MP;LECOCQ, JP
通讯作者: LECOCQ, JP